We aimed to the addition of synthetic 3-hydroxy-3-methyglutaryl coenzyme A ( HMG-CoA ) reductase inhibitor , simvastatin to capecitabine-cisplatin ( XP ) in patients with previously untreated advanced gastric cancer ( AGC ) .